WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$34.71
+0.58% today
Updated 2026-05-06
Market cap
$1.91B
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$55 – $171
Volume
1.0M
GeneDx Holdings Corp. (WGS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.73M | $-93.13M | $-190.43M | $-319.15M | $-180.15M | $-28.50M | $33.28M |
| Capital expenditures | $15.46M | $31.97M | $20.79M | $14.32M | $5.71M | $5.49M | $19.02M |
| Depreciation | $6.41M | $11.73M | $21.81M | $59.31M | $35.83M | $21.95M | — |
| Stock-based comp | $5.48M | $120.23M | $219.42M | $41.98M | $-326000.00 | $9.14M | $32.16M |
| Free cash flow | $-34.18M | $-125.10M | $-211.22M | $-333.48M | $-185.86M | $-33.99M | $14.26M |
| Investing cash flow | $-15.46M | $-31.97M | $-20.79M | $-141.33M | $-43.73M | $-30.13M | — |
| Financing cash flow | $148.01M | $129.06M | $493.73M | $197.31M | $186.24M | $44.16M | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-263.17M | — | — | — |